Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Timucin Avsar, Berfu Nur Yigit, Gizem Turan, Deniz Altunsu, Seyma Calis, Bahar Kurt, Turker Kilic, M. Yavuz Ergun, Serdar Durdagi & Melih Acar. (2021) Development of imidazolone based angiotensin II receptor type I inhibitor small molecule as a chemotherapeutic agent for cell cycle inhibition. All Life 14:1, pages 678-690.
Read now
Read now
Ramin Ekhteiari Salmas, Serdar Durdagi, Mehmet Fuat Gulhan, Merve Duruyurek, Huda I. Abdullah & Zeliha Selamoglu. (2018) The effects of pollen, propolis, and caffeic acid phenethyl ester on tyrosine hydroxylase activity and total RNA levels in hypertensive rats caused by nitric oxide synthase inhibition: experimental, docking and molecular dynamic studies. Journal of Biomolecular Structure and Dynamics 36:3, pages 609-620.
Read now
Read now
Articles from other publishers (20)
Kalliopi Moschovou, Maria Antoniou, Eleni Chontzopoulou, Konstantinos D. Papavasileiou, Georgia Melagraki, Antreas Afantitis & Thomas Mavromoustakos. (2023) Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein. International Journal of Molecular Sciences 24:21, pages 15894.
Crossref
Crossref
Sofia Kiriakidi, Zoe Cournia & Thomas Mavromoustakos. 2022. Cholesterol. Cholesterol
147
168
.
Nikitas Georgiou, Vasileios K. Gkalpinos, Spyridon D. Katsakos, Stamatia Vassiliou, Andreas G. Tzakos & Thomas Mavromoustakos. (2021) Rational Design and Synthesis of AT1R Antagonists. Molecules 26:10, pages 2927.
Crossref
Crossref
Eleni Chontzopoulou, Andreas G. Tzakos & Thomas Mavromoustakos. (2020) On the Rational Drug Design for Hypertension through NMR Spectroscopy. Molecules 26:1, pages 12.
Crossref
Crossref
Marcos V. Perini, Rhynelle S. Dmello, Tracy L. Nero & Ashwini L. Chand. (2020) Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments. Pharmacology & Therapeutics 211, pages 107527.
Crossref
Crossref
Zhoulong Fan, Katherine L. Bay, Xiangyang Chen, Zhe Zhuang, Han Seul Park, Kap‐Sun Yeung, K. N. Houk & Jin‐Quan Yu. (2020) Rational Development of Remote C−H Functionalization of Biphenyl: Experimental and Computational Studies. Angewandte Chemie International Edition 59:12, pages 4770-4777.
Crossref
Crossref
Zhoulong Fan, Katherine L. Bay, Xiangyang Chen, Zhe Zhuang, Han Seul Park, Kap‐Sun Yeung, K. N. Houk & Jin‐Quan Yu. (2020) Rational Development of Remote C−H Functionalization of Biphenyl: Experimental and Computational Studies. Angewandte Chemie 132:12, pages 4800-4807.
Crossref
Crossref
Serdar Durdagi, Ismail Erol, Ramin Ekhteiari Salmas, Busecan Aksoydan & Isik Kantarcioglu. (2019) Oligomerization and cooperativity in GPCRs from the perspective of the angiotensin AT1 and dopamine D2 receptors. Neuroscience Letters 700, pages 30-37.
Crossref
Crossref
Renata Toplak Časar & Zdenko Časar. (2018) Development of efficient one-pot three-component assembly of trityl olmesartan medoxomil. Bioorganic & Medicinal Chemistry 26:14, pages 4348-4359.
Crossref
Crossref
Y.-H. Dong, Y. Jin, T. N. Tsacogianis, M. He, P.-H. Hsieh & J. J. Gagne. (2018) Use of olmesartan and enteropathy outcomes: a multi-database study. Alimentary Pharmacology & Therapeutics 47:6, pages 792-800.
Crossref
Crossref
Serdar Durdagi, Busecan Aksoydan, Ismail Erol, Isik Kantarcioglu, Yavuz Ergun, Gulay Bulut, Melih Acar, Timucin Avsar, George Liapakis, Vlasios Karageorgos, Ramin E. Salmas, Barış Sergi, Sara Alkhatib, Gizem Turan, Berfu Nur Yigit, Kutay Cantasir, Bahar Kurt & Turker Kilic. (2018) Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferation. European Journal of Medicinal Chemistry 145, pages 273-290.
Crossref
Crossref
Ismail Erol, Busecan Aksoydan, Isik Kantarcioglu & Serdar Durdagi. 2018. Rational Drug Design. Rational Drug Design
431
448
.
Busecan Aksoydan, Isik Kantarcioglu, Ismail Erol, Ramin Ekhteiari Salmas & Serdar Durdagi. (2017) Structure-Based Design of hERG-Neutral Antihypertensive Oxazalone and Imidazolone Derivatives. Journal of Molecular Graphics and Modelling.
Crossref
Crossref
Busecan Aksoydan, Isik Kantarcioglu, Ismail Erol, Ramin Ekhteiari Salmas & Serdar Durdagi. (2017) Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives. Journal of Molecular Graphics and Modelling 77, pages 240-249.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
329
356
.
Elisabeth Fabian, Dietmar Schiller, Heimo Wenzl, Carolin Lackner, Josef Donnerer, Alexander Ziachehabi, Rene Silye, Rainer Sch?fl & Guenter J. Krejs. (2015) Clinical-Pathological Conference Series from the Medical University of Graz. Wiener klinische Wochenschrift 127:23-24, pages 974-980.
Crossref
Crossref
A. Sadeghpour, M. Rappolt, D. Ntountaniotis, P. Chatzigeorgiou, K. Viras, G. Megariotis, M.G. Papadopoulos, E. Siapi, G. Mali & T. Mavromoustakos. (2015) Comparative study of interactions of aliskiren and AT 1 receptor antagonists with lipid bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes 1848:4, pages 984-994.
Crossref
Crossref
Tahsin Kellici, Andreas Tzakos & Thomas Mavromoustakos. (2015) Rational Drug Design and Synthesis of Molecules Targeting the Angiotensin II Type 1 and Type 2 Receptors. Molecules 20:3, pages 3868-3897.
Crossref
Crossref
G. Ianiro, S. Bibb?, M. Montalto, R. Ricci, A. Gasbarrini & G. Cammarota. (2014) Systematic review: sprue-like enteropathy associated with olmesartan. Alimentary Pharmacology & Therapeutics 40:1, pages 16-23.
Crossref
Crossref
John KuchteyRachel W. Kuchtey. (2014) The Microfibril Hypothesis of Glaucoma: Implications for Treatment of Elevated Intraocular Pressure. Journal of Ocular Pharmacology and Therapeutics 30:2-3, pages 170-180.
Crossref
Crossref